Keith Fandrick
Vermogen: - $ op 30-09-2026
Vermogen: - $ op 30-09-2026
Dr. Keith R.
Fandrick is a Chief Operating Officer at IRulya Therapeutics, Inc. Dr. Fandrick was previously employed as a Chief Operating Officer by OrphAI Therapeutics, Inc. He received his undergraduate degree from the University of California, a graduate degree from Harvard University, an MBA from Kenan-Flagler Business School and a doctorate degree from Harvard University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 08-10-2026 | 0 ( -.--% ) | - $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| IRULYA THERAPEUTICS INC. | Operationeel Directeur | 08-10-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
AI Therapeutics, Inc.
AI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing therapies for pulmonary diseases | Operationeel Directeur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kenan-Flagler Business School
Kenan-Flagler Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quince Therapeutics, Inc.
Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
AI Therapeutics, Inc.
AI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing therapies for pulmonary diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau